Professor Johanna Olweus, leader of the Experimental Immunotherapy Group at the Department of Cancer Immunology, has been selected for the final of the Cancer Grand Challenges as part of a global research team. If successful, the team hopes to contribute in giving cancer patients new therapies.
"Reaching the final in competition with top research teams from all over the world is incredibly exciting and a great recognition of the work of my group," says Johanna Olweus.
Olweus is a professor at the Institute of Clinical Medicine, at the University of Oslo. She is also the deputy head of PRIMA - Center for Precision Immunotherapy, a new Center of Excellence at University of Oslo and Oslo University Hospital.
"I feel humbled and proud to have been invited to join a team consisting of some of the world's leading experts in structural, molecular, and cellular immunology and artificial intelligence," she says.
Cancer Grand Challenges (CGC) is a funding initiative co-founded by Cancer Research UK and the National Cancer Institute (NCI) in the US to take on some of the toughest challenges in cancer.
Complete original news article from the UiO home page:
Johanna Olweus part of research team shortlisted for Cancer Grand Challenges funding